Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2086581
Max Phase: Preclinical
Molecular Formula: C35H42N8O4
Molecular Weight: 638.77
Molecule Type: Small molecule
Associated Items:
ID: ALA2086581
Max Phase: Preclinical
Molecular Formula: C35H42N8O4
Molecular Weight: 638.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)Cn2cc(-c3ccc(-n4cnc5c(N)ncnc54)cc3)nn2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C35H42N8O4/c1-6-33(4)15-26(34(5)20(2)11-13-35(21(3)30(33)46)14-12-25(44)29(34)35)47-27(45)17-42-16-24(40-41-42)22-7-9-23(10-8-22)43-19-39-28-31(36)37-18-38-32(28)43/h6-10,16,18-21,26,29-30,46H,1,11-15,17H2,2-5H3,(H2,36,37,38)/t20-,21+,26-,29+,30+,33-,34+,35+/m1/s1
Standard InChI Key: QZUTTXSQDMFTQC-OPQGOLPDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 638.77 | Molecular Weight (Monoisotopic): 638.3329 | AlogP: 4.56 | #Rotatable Bonds: 6 |
Polar Surface Area: 163.93 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 4.35 | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 4 | Heavy Atoms: 47 | QED Weighted: 0.23 | Np Likeness Score: 0.58 |
1. Dreier I, Kumar S, Søndergaard H, Rasmussen ML, Hansen LH, List NH, Kongsted J, Vester B, Nielsen P.. (2012) A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity., 55 (5): [PMID:22280300] [10.1021/jm201266b] |
2. Dreier I, Hansen LH, Nielsen P, Vester B.. (2014) A click chemistry approach to pleuromutilin derivatives. Part 3: extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chain., 24 (4): [PMID:24486133] [10.1016/j.bmcl.2014.01.019] |
3. Heidtmann CV,Voukia F,Hansen LN,Sørensen SH,Urlund B,Nielsen S,Pedersen M,Kelawi N,Andersen BN,Pedersen M,Reinholdt P,Kongsted J,Nielsen CU,Klitgaard JK,Nielsen P. (2020) Discovery of a Potent Adenine-Benzyltriazolo-Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA., 63 (24): [PMID:33325700] [10.1021/acs.jmedchem.0c01328] |
Source(1):